Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 62.01% vs 4.65% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -1.29% vs 10.47% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 12.44% vs 10.22% in Mar 2025
Compare Balance Sheet Results of Aristo Bio-Tech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.81
24.95
-18.14
-72.71%
Share Warrants & Outstandings
Total Reserve
37.30
57.14
-19.84
-34.72%
Shareholder's Funds
44.11
99.06
-54.95
-55.47%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
7.63
18.83
-11.20
-59.48%
Secured Loans
7.35
18.83
-11.48
-60.97%
Unsecured Loans
0.28
0.00
0.28
0.00%
Deferred Tax Assets / Liabilities
0.01
-1.47
1.48
100.68%
Other Long Term Liabilities
0.00
0.42
-0.42
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
7.64
17.78
-10.14
-57.03%
Current Liabilities
Trade Payables
70.85
6.28
64.57
1,028.18%
Other Current Liabilities
4.85
3.97
0.88
22.17%
Short Term Borrowings
27.77
20.75
7.02
33.83%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
103.47
30.99
72.48
233.88%
Total Liabilities
155.22
147.83
7.39
5.00%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
37.37
58.23
-20.86
-35.82%
Less: Accumulated Depreciation
13.74
37.24
-23.50
-63.10%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
23.64
20.99
2.65
12.63%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
22.04
-22.04
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.18
0.10
0.08
80.00%
Long Term Loans & Advances
0.07
5.68
-5.61
-98.77%
Other Non Current Assets
1.17
0.00
1.17
0.00%
Total Non-Current Assets
25.06
48.81
-23.75
-48.66%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
63.21
31.54
31.67
100.41%
Sundry Debtors
54.73
53.90
0.83
1.54%
Cash and Bank
2.63
2.39
0.24
10.04%
Other Current Assets
0.41
4.95
-4.54
-91.72%
Short Term Loans and Advances
9.18
6.24
2.94
47.12%
Total Current Assets
130.16
99.02
31.14
31.45%
Net Current Assets (Including Current Investments)
26.69
68.03
-41.34
-60.77%
Total Current Assets Excluding Current Investments
130.16
99.02
31.14
31.45%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
155.22
147.83
7.39
5.00%
Contingent Liabilities
0.36
12.95
-12.59
-97.22%
Total Debt
35.40
39.57
-4.17
-10.54%
Book Value per share (adjusted)
64.79
28.69
36.10
125.83%
Annual - Borrowings
Borrowings 35.40 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 62.01% vs 4.65% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 23.64 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.29% vs 10.47% in Mar 2025
Annual - Investments
Investments 0.18 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 130.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.44% vs 10.22% in Mar 2025
Footer loading
